UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000021840
Receipt No. R000025183
Official scientific title of the study Adhibition for Clopidogrel loading dose in acute ischemic stroke
Date of disclosure of the study information 2016/04/12
Last modified on 2018/10/10 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Adhibition for Clopidogrel loading dose in acute ischemic stroke
Title of the study (Brief title) CLD in stroke
Region
Japan

Condition
Condition Acute ischemic stroke
Classification by specialty
Neurology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Test the efficacy and safety of oral clopidogrel 300 mg administration
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Hemorrhagic complication and recurrent stroke of the start of the onset of ischemic stroke within three weeks.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Clopidogrel 300 mg
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
90 years-old >=
Gender Male and Female
Key inclusion criteria Acute ischemic stroke patients within three days
Key exclusion criteria pancytopenia
severe liver dysfunction and/or renal dysfunction
hemorrhagic transformation in brain CT or MRI
active hemorrhagic lesion
Target sample size 50

Research contact person
Name of lead principal investigator Kazuo Kitagaza
Organization Tokyo Women's Medical University
Division name Department of Neurology
Address Kawada-cho 8-1, Shinjuku-ku, Tokyo, Japan.
TEL 03-3353-8111
Email kkitagawa@nij.twmu.ac.jp

Public contact
Name of contact person Sono Toi
Organization Tokyo Women's Medical University
Division name Department of Neurology
Address Kawada-cho 8-1, Shinjuku-ku, Tokyo, Japan.
TEL +81-3-3353-8111
Homepage URL
Email stoi@nij.twmu.ac.jp

Sponsor
Institute Department of Neurology, Tokyo Women's Medical University
Institute
Department

Funding Source
Organization Department of Neurology, Tokyo Women's Medical University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東京女子医科大学 神経内科

Other administrative information
Date of disclosure of the study information
2016 Year 04 Month 12 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2016 Year 03 Month 18 Day
Anticipated trial start date
2016 Year 04 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 04 Month 08 Day
Last modified on
2018 Year 10 Month 10 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000025183